Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Genomic Health, Inc., a leader in precision medicine, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2000, the company has made significant strides in the field of genomic testing, particularly in oncology, with its innovative assays that help guide treatment decisions for cancer patients.
The company’s flagship products, including the Oncotype DX® test, are designed to assess the likelihood of cancer recurrence and the potential benefit of chemotherapy, setting them apart in the personalised medicine landscape. Genomic Health has established a strong market position, recognised for its commitment to improving patient outcomes through advanced genomic insights. With numerous accolades and a robust portfolio, Genomic Health continues to shape the future of cancer care.
-17 vs industry average
Genomic Health, Inc.’s score of 25 is lower than 42% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Genomic Health, Inc. yet.
Genomic Health, Inc., headquartered in the US, currently does not have available emissions data for the most recent year. As a result, specific figures regarding their carbon emissions, including Scope 1, 2, and 3 totals, are not provided.
However, it is important to note that Genomic Health, Inc. is a current subsidiary of Exact Sciences Corporation, which may influence its climate commitments and emissions reporting. The climate initiatives and reduction targets of Genomic Health are likely aligned with those of Exact Sciences Corporation, although specific targets or achievements for Genomic Health itself have not been disclosed.
As part of its corporate family, Genomic Health may benefit from the sustainability strategies and climate pledges established by Exact Sciences Corporation, which operates under various initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). These initiatives aim to promote transparency and accountability in emissions reductions, although specific details regarding Genomic Health's commitments remain unspecified.
In summary, while Genomic Health, Inc. does not currently report emissions data or specific reduction targets, its affiliation with Exact Sciences Corporation suggests a potential alignment with broader climate commitments within the industry.
No climate goals have been disclosed for Genomic Health, Inc. yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Genomic Health, Inc. yet.
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more